Hyderabad firm develops first CORONAVIRUS vaccine COVAXIN!

Hyderabad firm develops first CORONAVIRUS vaccine COVAXIN

Amid the COVID-19 pandemic, Hyderabad’s Bharat Biotech has made a surprising announcement.

It said it developed the COVAXIN vaccine for the deadly coronavirus.

It becomes India’s first COVID vaccine candidate who got a nod from Drug Controller General of India (DCGI) for human trials.

According to the reports, COVAXIN is the first vaccine to get a nod from DCGI for phase I and II human trials.

Bharat Biotech has collaborated with the Indian Council of Medical Research (ICMR) and the National Institute of Virology, Pune in developing the vaccine for the virus.

The human trIals will be REPORTEDLY begin across India in July.

Click the video for more.

Hyderabad firm develops first CORONAVIRUS vaccine COVAXIN
Hyderabad firm develops first CORONAVIRUS vaccine COVAXIN

Leave a Reply